… diseases. In this report we revise P. jirovecii colonization in different chronic pulmonary
diseases such us, chronic obstructive pulmonary disease, interstitial lung diseases, cystic fibrosis …

… jirovecii in ILDs, as a subgroup of respiratory diseases [5, 6], and the present study is the
first to include a relatively large number of patients with ILDs. A predominance of males was …

… progression, particularly in chronic obstructive pulmonary disease (COPD), has been
investigated and is discussed in detail below. The prevalence of colonization varies with the …

… Pneumocystis jirovecii–specific DNA in prospectively obtained oropharyngeal wash samples
from 50 persons without underlying lung disease or … Patients with pulmonary disorders may …

… Pneumocystis jirovecii is the only fungus of its kind to be pathogenic in humans. It is primarily
responsible for pneumonia (PJP). The key to understanding immune defences has focused …

… Pneumocystis jirovecii pneumonia (PcP) was an early … The incidence of PcP associated with
HIV has fallen, a result of earlier … to differentiate PcP from other respiratory infections and/or …

… Pneumocystis pneumonia is an opportunistic disease caused by invasion of unicellular fungus
Pneumocystis jirovecii. … Thus, pulmonary disorders may be both predisposing factors for …

… in rheumatology include older age (>65 years old), coexisting pulmonary disease and the
use of glucocorticoids [82]. When initiating prophylaxis in patients with two or three risk factors …

… in rats and proposed the name Pneumocystis carinii [Citation2]. Pneumocystis would not be
… pneumonia such as cyanosis, low-grade fever, and respiratory distress. Prior to the 1980s …

… We confirmed age as well as pre-existing pulmonary disease as risk factors for mortality.
This analysis produced very large confidence intervals as a result of the small sample size. The …